Company
Fortis Therapeutics
PROPRIETARY, PRECISION THERAPIES.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- La Jolla, California, United States
Claim, correct or request removal
Record updated 28 September 2026
About
Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies against CD46 for the treatment of late-stage multiple myeloma and late-stage prostate cancer and other indications.
Funding snapshot
- Total raised
- $58MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series A, $40M2021-03-29
Funding rounds
- Series A
- $40M2021-03-29, Company stated
- Series A
- $18M2018-11-06, Company stated
Loading relationship preview